{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:55:37Z","timestamp":1777859737417,"version":"3.51.4"},"reference-count":13,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:p>Systemic absorption of oral vancomycin for the treatment of Clostridium difficile is thought to be trivial in patients without risk factors for increased systemic absorption and is often overlooked in clinical practice. A 51-year-old male elicits a suspected immunoglobulin E-mediated hypersensitivity following administration of low-dose oral vancomycin for the treatment of severe C difficile. The patient had normal renal function and was administered low doses of the medication, however, had a medical history significant for diverticulitis. Applying the Naranjo adverse drug reaction probability scale, a score of 5 was obtained, indicating a probable association between the administration of oral vancomycin and the hypersensitivity reaction. This case demonstrates that hypersensitivity reactions following low-dose oral vancomycin administration in patients with severe C difficile are possible, despite having normal renal function. Other risk factors for systemic absorption of oral vancomycin need to be evaluated in the literature, including severity of disease and underlying gastrointestinal processes.<\/jats:p>","DOI":"10.1177\/0897190016668437","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T20:32:59Z","timestamp":1473885179000},"page":"650-652","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Hypersensitivity Reaction Following Administration of Low-Dose Oral Vancomycin for the Treatment of\n                    <i>Clostridium difficile<\/i>\n                    in a Patient With Normal Renal Function"],"prefix":"10.1177","volume":"30","author":[{"given":"Laura J.","family":"Baumgartner","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Brown","sequence":"additional","affiliation":[{"name":"Touro University California College of Pharmacy, Vallejo, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curt","family":"Geier","sequence":"additional","affiliation":[{"name":"San Francisco General Hospital and Trauma Center, San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"bibr1-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1086\/651706"},{"issue":"5","key":"bibr2-0897190016668437","first-page":"949","volume":"4","author":"Hedge DD","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"bibr3-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.4.634"},{"key":"bibr4-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(87)80146-4"},{"issue":"4","key":"bibr5-0897190016668437","first-page":"533","volume":"100","author":"Spitzer PG","year":"1984","journal-title":"Arch Inn Med"},{"issue":"1","key":"bibr6-0897190016668437","first-page":"1","volume":"4","author":"Thompson CM","year":"1983","journal-title":"Int J Pediatr Nephrol"},{"key":"bibr7-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1538"},{"key":"bibr8-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1086\/591282"},{"key":"bibr9-0897190016668437","unstructured":"Ruef C, Blaser J, Maurer P, Meyler\u2019s Side Effects of Drugs: An Encyclopedia of Adverse Reactions and Interactions. 13th ed. Amserstdam, The Netherlands: Elsevier Science BV; 1996:757\u2013758."},{"key":"bibr10-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1177\/106002809102501207"},{"key":"bibr11-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"bibr12-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2009.00426.x"},{"key":"bibr13-0897190016668437","doi-asserted-by":"publisher","DOI":"10.1097\/01.smj.0000216477.06918.a3"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190016668437","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0897190016668437","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0897190016668437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:36:40Z","timestamp":1777509400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0897190016668437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1177\/0897190016668437"],"URL":"https:\/\/doi.org\/10.1177\/0897190016668437","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}